Share:
Bill Information - History
House Bill 943; Regular Session 2019-2020
Sponsors:
GAYDOS, RAPP, BARRAR, BERNSTINE, BROWN, SCHLEGEL CULVER, DeLUCA, HERSHEY, KAUFFMAN, KEEFER, MILLARD, B. MILLER, MIZGORSKI, MOUL, MULLINS, PASHINSKI, PICKETT, PYLE, SAINATO, SCHWEYER, SIMS, STRUZZI, STURLA, TOEPEL, WHEELAND, LONGIETTI, GLEIM, KNOWLES, CIRESI, BURNS, DEASY, MATZIE, SCHMITT, EVERETT, KLUNK, READSHAW, GREINER, DUSH, SAYLOR, SCHLOSSBERG, HEFFLEY, RIGBY, McNEILL, OWLETT, MASSER, ISAACSON, QUINN, WILLIAMS, NEILSON, WENTLING, TOOHIL, WARREN, GABLER, T. DAVIS, SOLOMON and HARKINS
Short Title:
An Act providing for consumer prescription drug pricing disclosure and pharmacy freedom to communicate.
Actions:
| PN 1587 | Referred to HEALTH, April 29, 2019 |
|
| PN 2089 | Reported as amended, June 11, 2019 |
|
Re-committed to RULES, June 11, 2019 |
||
Re-reported as committed, Sept. 17, 2019 |
||
Removed from table, Oct. 30, 2019 |
||
Re-committed to APPROPRIATIONS, Nov. 19, 2019 |
||
Re-reported as committed, Nov. 20, 2019 |
||
Third consideration and final passage, Nov. 20, 2019 (197-0) |
||
In the Senate |
||
Referred to HEALTH AND HUMAN SERVICES, Nov. 22, 2019 |
||
| PN 3655 | Reported as amended, April 28, 2020 |
|
Re-referred to APPROPRIATIONS, April 29, 2020 |
||
Re-reported as committed, June 24, 2020 |
||
| PN 4053 | Amended on third consideration, June 29, 2020 |
|
Third consideration and final passage, June 30, 2020 (50-0) |
||
In the House |
||
Referred to RULES, July 7, 2020 |
||
Re-reported on concurrence, as committed, July 7, 2020 |
||
House concurred in Senate amendments, July 7, 2020 (201-0) |
||
Signed in House, July 7, 2020 |
||
Signed in Senate, July 13, 2020 |
||
Presented to the Governor, July 13, 2020 |
||
Approved by the Governor, July 23, 2020 |
||
Act No. 67 of 2020, July 23, 2020 |
* denotes current Printer's Number